Global Pharmacogenetics Testing in PsychiatryDepression Market

Global Pharmacogenetics Testing in PsychiatryDepression Market

The global pharmacogenetics testing in psychiatry/depression market is expected to reach USD 2,664,382.70 thousand by 2031 from USD 1,224,473.84 thousand in 2023, growing with a CAGR of 10.4% in the forecast period of 2024 to 2034.

Market Segmentation

Global Pharmacogenetics Testing in Psychiatry/Depression Market, By Type (Anxiety, Mood Disorders, Depression, Bipolar Disorders, Psychotic Disorders, and Eating Disorders), Test Type (Whole Genome Sequencing and Chromosomal Array-Based Tests), Patient Type (Child, Adults, and Geriatric), Gene Type (CYP2C19, CYP2C9 and VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4, SLC6A4, MTHFR, COMT, and Others), Products (Instruments, Consumables, and Software and Services), End User (Hospitals and Clinics, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distribution, Hospital Pharmacy, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Turkey, Belgium, Netherlands, Switzerland, Denmark, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Philippines, Malaysia, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Global Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics

Driver
• Rising number of population suffering from depressive disorder

Restraint
• Insufficient clinical validation

Opportunity
• Advancements in genetic testing

Market Players

Some of the major market players operating in the global pharmacogenetics testing in psychiatry/depression market are listed below:
• ThermoFisher Scientific Inc. (U.S.)
• Illumina Inc. (U.S.)
• Myriad Genetics Inc. (U.S.)
• Sonic Healthcare Limited (Australia)
• QIAGEN (Germany)
• AB-BIOTICS S.A. (Spain)
• BiogeniQ Inc. (Canada)
• Castle Bioscience Inc. (U.S.)
• Coriell Life Sciences (U.S.)
• Dynamic DNA Laboratories (U.S.)
• Eurofins Scientific (Luxembourg)
• Genelex (U.S.)
• Genewiz (U.S.)
• Genomind Inc. (U.S.)
• GenXys (Canada)
• HealthSpek (U.S.)
• HudsonAlpha (U.S.)
• MD Labs (U.S.)
• ONEOME LLC (U.S.)
• PacBio (U.S.) Show more